Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1273017-03-0

C22H34N2O6 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1273017-03-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1273017-03-0 Structure

  • Basic information

    1. Product Name: C22H34N2O6
    2. Synonyms: C22H34N2O6
    3. CAS NO:1273017-03-0
    4. Molecular Formula:
    5. Molecular Weight: 422.522
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1273017-03-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C22H34N2O6(CAS DataBase Reference)
    10. NIST Chemistry Reference: C22H34N2O6(1273017-03-0)
    11. EPA Substance Registry System: C22H34N2O6(1273017-03-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1273017-03-0(Hazardous Substances Data)

1273017-03-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1273017-03-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,3,0,1 and 7 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1273017-03:
(9*1)+(8*2)+(7*7)+(6*3)+(5*0)+(4*1)+(3*7)+(2*0)+(1*3)=120
120 % 10 = 0
So 1273017-03-0 is a valid CAS Registry Number.

1273017-03-0Downstream Products

1273017-03-0Relevant articles and documents

PRODRUGS OF GUANFACINE

-

, (2011/04/18)

Prodrugs of guanfacine with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration, as well as improving the pharmacokinetics of guanfacine are provided herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1273017-03-0